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Abstract Phenolic compounds are of considerable
biomedical interest due to their antioxidant properties
and potential in the prevention and possibly treatment
of many chronic diseases. The fruits, leaves and root
bark of Morus nigra (Moraceae), the black mulberry
tree, have a long history of use for various therapeutic
purposes in traditional medicine worldwide. The roots
of the plant are known to be a rich source of phenolic
compounds with a particularly high chemical diver-
sity. This mini-review compiles the currently available
knowledge on phenolic compounds reported from
Morus nigra roots, and provides a brief overview on
the antioxidant activity with a focus on the available
in vivo evidence. Morusin, a major phenolic antiox-
idant of the root bark, has attracted a rapidly increasing
scientific interest for its versatile and potent antitumor
properties; recent developments in this regard, includ-
ing morusin’s promising activity against cancer stem
cells, are also discussed in the paper.
Keywords Anticancer activity of prenylflavone 
Black mulberry root bark  Cancer stem cell 
Ethnopharmacology  In vivo antioxidant activity
Introduction
The Morus genus, belonging to the Moraceae family,
comprises of twenty-four species with one subspecies,
and has ca. one hundred known varieties to date
(Ercisli and Orhan 2007; Hojjatpanah et al. 2011).
Well known as the ‘‘black mulberry tree’’, Morus
nigra L. has long been valued for its fruit, which has
also been claimed as a ‘‘super fruit’’ that has various
health benefits and promotes longevity (Bircher and
Bircher 2000).Morus nigra is a wildly growing rustic
plant that is also present in many gardens and,
similarly to other Morus species and M. alba in
particular, it was also used for sericulture (Hanelt et al.
2001; Orwa et al. 2009). Morus nigra often produces
leaves of different shapes, and these multilobed leaves
can appear on the same branches. The fruit is
blackberry-shaped and typically black but sometimes
dark blue in color, with a sweet taste. Despite popular
belief, the color of the fruit alone does not determine
the mulberry species; instead, the leaves and wood
characteristics should be taken into account for an
exact identification (Orwa et al. 2009).
The plant has a long and remarkable history. Likely
introduced to Europe originally from Persia, its
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cultivation on the Continent appears to date back
thousands of years (Huxley and Taylor 1989). The
ancient Greeks dedicated the fruit to Minerva, the
goddess of wisdom. Black mulberry was abundant in
Italy during the Roman era; it was also depicted in the
paintings from Pompeii (Georgics ii verse 121;
Schreiber 1958). Mulberry has also been acknowl-
edged in the Bible (I Maccabees 6:34; Luke 17:5-6).
Black mulberry leaves were considered as the feed for
Italian silkworms until 1434 when Morus alba was
introduced from the Levantine lands (Vivarelli and
Alvisi 1934). During the ‘‘silk revolution’’ in 1608, the
practice of sericulture was introduced to Britain by
promoting mulberry cultivation (Grieve 1931).
Although its medicinal use was an ancient practice,
it was the growing silk industry that brought this plant
into the spotlight, resulting in the worldwide spreading
of mulberry trees to satisfy industrial needs for
mulberry leaves (Lev 2002). Despite black mulberry
is in fact more nutritive than Morus alba, the white
mulberry (Venkatesh and Chauhan 2008), its impor-
tance has finally been surpassed by that because of its
weaker success in feeding silkworms. The nutritive
richness of black mulberry, however, still makes it an
excellent animal feed that also enhances the milk yield
of dairy animals (Dillard and Bruce German 2000).
The root bark of M. nigra also plays an important
economical role through its use to prepare ‘artificial
cotton’ textile fiber, paper and clothes (Hanelt et al.
2001; Lim 2012). Besides its use as livelihood, the
long history of Morus nigra includes its therapeutic
use in practically every era of traditional medicine,
under different names, and with various, frequently
different uses in each system (Leonti et al. 2015).
Ancient Egyptians used the plant preparations for
corroding ulcers and dispersing inflamed tumors, and
the bark juice was an antidote to the venom of deadly
snakes (Pliny the Elder 2015). Morus nigra has been
used in Ayurveda, one of the oldest holistic healing
systems dating ca. 600 B.C. Many M. nigra formula-
tions are still in use in Ayurvedic medicine, e.g.
against cancer (Tut-i-aswad, containing the fruits)
(Ahmad et al. 1985), and for treating sore throat or
laryngitis (Rub-e-toot siyah, containing the root bark)
(Khare 2010). The roots of Morus plants were
recorded in the Chinese pharmacopeia in 500 B.C.
collectively known as sang-Bi-Pi often used for
treating lung heat, cough, edema, and oliguria (Phar-
macopoeia Committee of P. R. China 2010). The roots
and bark of black mulberry are known folk remedy for
diabetes, arthritis, and hypertension, and as diuretics
(Abbas et al. 2014; Ribeiro et al. 2017). The root bark
has anthelmintic activity, and it is also used to treat
bronchitis (Mohiuddin et al. 2011), as well as a
purgative agent (Hanif and Singh 2012). The roots of
M. nigra contain an outstandingly rich variety of
phenolic compounds, which compound family is
likely among the most important constituents related
to the therapeutic benefits associated with traditional
preparations (Manach et al. 1997).
The chemistry and pharmacology ofMorus species,
and particularly of M. alba, served as the basis of
several recent reviews (e.g. Chan et al. 2016; Hussain
et al. 2017; Yaun and Zhao 2017), indicating well the
very high current scientific interest in these plants.
Bioactive constituents of Sang-Bai-Pi, root bark of
various Morus plants, have recently been reviewed
from a general point of view (Wei et al. 2016). In the
present paper, we aim to set a more specific focus on
(i) the phenolic compounds isolated from the roots of
M. nigra, (ii) the in vivo evidence supporting their
antioxidant activity, and (iii) the antitumor activity of
morusin, a new ‘‘rising star’’ among the major
phenolic antioxidants of M. nigra root bark.
Phenolic composition of Morus nigra
All Morus species are known as rich sources of
phenolic compounds including flavonoids, stilbenes,
2-arylbenzopyrans, and a variety of Diels–Alder
adducts (Nomura 1988; Nomura and Hano 1994),
and, according to many comparative studies,M. nigra
appears to be the richest of all in this regard (Ercisli
and Orhan 2007; Wang et al. 2007; Ercisli et al. 2009;
Arfan et al. 2012). As an example, a comparison with
M. alba revealed thatM. nigra has a higher content of
reduced ascorbic acid, titratable acidity, iron, total
flavonoids and total monomeric anthocyanins (Jiang
and Nie 2015).
Flavonoids have a remarkable chemical diversity
not only due to their variability in hydroxylation/
methoxylation pattern, but mainly due to the many
possibilities for being further substituted with sugars,
prenyl and geranyl groups, esterified with organic
acids, etc., and many of these substituents open
possibilities to further cyclization. In particular, the
root bark ofMorus nigra contains a remarkable variety
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of prenylflavonoids (Ferrari et al. 1999, Wang et al.
2007, 2008, 2009, Zheng et al. 2010, De Souza et al.
2000, Simonetti et al. 2017, Zelova et al. 2014), as
presented in Fig. 1. Interestingly, phenolic compounds
isolated from the roots of Morus nigra L. showed
remarkable differences as compared to those biosyn-
thesized by cell culture of plant, based on a compar-
ative study of Ferrari et al. (1999). From the roots, the
flavonoids Kuwanon U, Cyclomorusin, Morusin
hydroperoxide, Morusin, Kuwanon C, Kuwanon E,
Morusinol, Norartocarpetin and seven Diels–Alder
type adducts (Albanol B, Kuwanon O, Kuwanon H,
Kuwanon G, Albafuran C, Kuwanon L, and Morace-
nin D) were isolated. In contrast to this, the callus gave
4-hydroxyisocordoin, oxyresveratrol, resveratrol, and
six Diels–Alder type adducts (Kuwanon V, Mulber-
rofuran E, Kuwanon R, Kuwanon J, Chalcomoracin,
and Kuwanol E). Above the remarkable lack of
compounds isolated from both sources, significant
differences could be observed in the stereochemistry
of the cyclohexene ring of Diels–Alder type adducts:
this was different for compounds from the cell culture
(cis–trans) and for those from the plant (trans–trans)
(Ferrari et al. 1999).
Geranylflavonoids
Three geranylflavonoids have been reported from M.
nigra roots, one flavone and two flavanone type, each
containing the geranyl group in the B-ring, connected
to C-50 (Fig. 2); the presence of an isoprenyl/geranyl
group at different positions in the B-ring of the
flavonoid skeleton significantly affects tyrosinase
inhibitory activity (Zheng et al. 2010).
Chalcones
Although it would be expected to contain a larger
variety of these compounds as well, up to now only
two chalchones have been reported from the roots of
M. nigra; structures of these compounds are presented
in Fig. 3. These chalcones were found more biolog-
ically potent in comparison with geranyl/prenyl
flavonoids concerning tyrosinase inhibitory activity
(Zheng et al. 2010).
Diels–Alder type adducts
The [4 ? 2]-Cycloaddition of a conjugated diene and
a dienophile to form a six-membered ring is a well-
known Diels–Alder reaction. Many of these classical
compounds are known to occur in the Morus genus,
and an immense variety of Diels–Alder type adducts
have so far been reported from the roots ofM. nigra, as
summarized in Fig. 4. Kuwanol E isolated from the
roots was found to be potent inhibitor of Mycobac-
terium tuberculosis protein tyrosine phosphatase B
(Mascarello et al. 2013, 2016). Recently, a similar
testing of other constituents of Morus nigra roots,
namely Cudraflavanone A, Morusin, Oxyresveratrol,
Chalcomoracin, Norartocarpetin, Kuwanon L, Kuwa-
non G, and Kuwanon H revealed the latter two
compounds as particularly potent inhibitors of above
enzyme of Mycobacterium tuberculosis (Mascarello
et al. 2018).
Arylbenzofurans and stilbenes
Morus nigra has widely been acknowledged as a rich
source of bioactive benzofuran derivatives and stilbe-
nes, among which the 2-arylbenzofurans are com-
monly substituted by prenyl and geranyl groups.
(Nguyen et al. 2009). Various bioactivities (e.g.
antifungal, antibacterial, etc.) associated with benzo-
furan derivatives make these compounds attractive
subjects for medicinal chemistry studies (Kone et al.
2004; Fukai et al. 2005; Zheng et al. 2010). Similarly
to prenylflavonoids, benzofurans can also inhibit nitric
oxide synthase, thus indirectly inhibiting the release of
a major inflammatory mediator, nitric oxide (Zelova
et al. 2014). Constituents of M. nigra roots with
2-phenylbenzofuran skeleton are presented in Fig. 5
(Wang et al. 2008; Zheng et al. 2010; Zelova et al.
2014). Although one more compound, morunigrol D,
appears in the literature as a constituent of the root
bark (Zelova et al. 2014), its presence in the roots
cannot unambiguously be declared here since it was in
fact isolated from the stem bark (Wang et al. 2010).
These compounds were reported with their tyrosinase
activity that was found to be lower in 2-arylbenzofuran
derivatives as compared to stilbene derivatives, sug-
gesting that formation of the five-membered ring
significantly affects this bioactivity (Zheng et al.
2010).
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Fig. 1 Prenylflavonoids from the roots of Morus nigra
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A number of stilbenes (Oxyresveratrol and three of
its O-b-D-glucopyranosides) have also been reported
from the roots of M. nigra; structures of these
compounds are presented in Fig. 6. Glycoside moi-
eties were suggested to significantly affect the tyrosi-
nase activity of stilbenes, and glycosidation at 2 or 4
position suppresses the activity to a much larger extent
than at the 30 or 50 position (Zheng et al. 2010).
Coumarins
Five coumarin glycosides, presented in Fig. 7, are
known to be present in the roots of M. nigra (Zheng
et al. 2010). Among these, mulberroside B is a
C-glycoside at C-6, while the others are O-glycosides
containing one or two sugar components connected to
the coumarin skeleton. In each of the latter ones, the
coumarin bears an O-b-D-glucoside at C-7, which can
be further glycosylated with a 6-deoxymannose or an
apiose (Fig. 7).
Antioxidant activity ofMorus nigra roots and their
constituents
Recent studies on M. nigra cover a rich variety of
constituents and a broad spectrum of bioactivities; in
this mini-review, we aim to focus on the antioxidant
activity. Since the roots ofMorus nigra are very rich in
phenolic compounds, such an effect might reasonably
be expected to significantly contribute at least to some
of the health benefits attributed to the traditional
preparations (Pandey and Rizvi 2009). Accordingly, it
is not surprising that a very large number of related
in vitro antioxidant studies are available. Strong free
radical scavenging effect was reported on various
extracts of black mulberry fruits, leaves or roots (e.g.
Naderi et al. 2004; Pe´rez-Gregorio et al. 2011) and/or
phenolic constituents in a number of in vitro exper-
imental models, and several related papers have been
published on the inhibition of xanthine oxidase or lipid
peroxidation (e.g. Radojkovic et al. 2016; Arfan et al.
2012; Imran et al. 2010).
A large number of in vitro antioxidant studies on
individual compounds are also available; here we
briefly summarize only a few characteristic examples.
Morusin, a major constituents of M. nigra roots,
showed inhibitory effect on superoxide formation from
rat neutrophils stimulated with phorbol myristate
acetate (PMA) (Ko et al. 1999). The benzofurans
moracin C and N were reported to scavenge superoxide
anion radical and inhibit lipid peroxidation (Sharma
et al. 2001). In a study aiming at the antioxidant activity
of four aryl benzofuran derivatives, moracin C, P, and
M, andmulberrosideC, two compounds,moracin C and
M were found particularly effective in the inhibition of
malondialdehyde (MDA) production during microso-
mal lipid peroxidation induced by ferrous cysteine (Tan
et al. 2008). The stilbene oxyresveratrol exerted
considerable superoxide scavenging effects (Oh et al.
2002). Among many other compounds in a series of
studies, albanol B, moracin M, and mulberrofuran G
Fig. 2 Geranylflavonoids from the roots of Morus nigra
Fig. 3 Chalcones from the roots of Morus nigra
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Fig. 4 Bioactive Diels–Alder type adducts from the roots of Morus nigra
1036 Phytochem Rev (2018) 17:1031–1045
123
were found particularly effective in the two most
common in vitro test for free radical scavenging,
namely the 2,20-azinobis-3-ethylbenzothiazoline-6-sul-
fonic acid (ABTS) and 1,1-diphenyl-2-picrylhydrazyl
(DPPH) assays (Cui et al. 2008; Fu et al. 2009), while
for example the prenylflavonoidsmorusin and kuwanon
C showed moderate DPPH radical scavenging activity
(Mazimba et al. 2011).
Despite there are many reports available on the
in vitro antioxidant activity of M. nigra root extracts
and constituents, vast majority of these have unfortu-
nately little if any in vivo relevance. It is now well
understood that there are significant pharmacokinetic
constraints, including complex interactions already
within the gastrointestinal tract (Dominguez-Avila
et al. 2017), weak absorption and extensive metabolism
(Rothwell et al. 2016), which are all limiting or altering
(Lotito et al. 2011) the in vivo bioactivity of orally
consumed phenolic antioxidants as compared to that
in vitro. Unfortunately, to the best of our knowledge, no
in vivo antioxidant studies are currently available with
preparations from M. nigra roots (or root bark).
Nevertheless, there are related reports on the fruits
and leaves, whose compositions certainly show over-
laps with that of the roots. Oral administration of a
crude, 95% ethanol extract of M. nigra fruits to mice
resulted in decreasing MDA content in the serum and
liver, accompanied by an increase of superoxide
Fig. 5 2-Arylbenzofurans from the roots of Morus nigra
Fig. 6 Stilbenes from the roots of Morus nigra. Glc = b-D-glucopyranoside
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dismutase (SOD), catalase (CAT) and glutathione
peroxidase (GSH-PX) activity (Feng et al. 2015).
Unfortunately, while the authors claimed this extract
as ‘‘total flavonoids of M. nigra’’, the chemical
composition remained uninvestigated, and ethanol is
a good extracting solvent of not only flavonoids but
also a wide variety of other types of secondary
metabolites. Accordingly, there might have been
several constituents in the studied extract (Feng et al.
2015) that are also present in the roots of the plant.
In another study, the methanol extract of M. nigra
leaves was found to protect DNA from UV-induced
damage, and, after oral administration, to protect mice
from D-galactose induced cerebral oxidative stress.
This latter effect manifested in a significantly less
profound cognitive impairment, lower malondialde-
hyde levels in the serum, liver and brain, as well as in
elevated SOD, GSH-PX, and CAT activities as
compared to those in the D-galactose treated group.
Since the utilized extract contained phenolic acids
such as vanillic acid and chlorogenic acid as chief
constituents (Turgut et al. 2016), it is hard to judge
what relevance other accompanying phenolic
compounds might have had in the observed activity.
Accordingly, it is also unclear whether or not a similar
effect could be expected from root extracts, since the
presence (and certainly the amounts, if any) of the
above-mentioned phenolic acids in the roots has not
yet been reported.
Investigating a traditional use widespread in Brazil,
the leaves of M. nigra were also studied for their
antidiabetic and antioxidant activity on streptozo-
tocin-induced diabetic rats, focusing on the maternal–
fetal outcome. The aqueous extract was used, and
while it was unable to control blood glucose levels, it
demonstrated a potent in vivo antioxidant activity:
increased SOD activity, decreased MDA levels were
found, and the offsprings from diabetic dams showed
reduced incidence of skeletal and visceral anomalies
upon treatment (Volpatoa et al. 2011). The extract was
prepared in the traditional way, i.e. boiling the dried
leaves in water, suggesting it to be likely rich in
phenolic acids and other water soluble substances
unlike similar root extracts. However, these conditions
likely also led to the extraction of a wide variety of less
polar constituents that could also be present in the
Fig. 7 Coumarins from the roots of Morus nigra
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roots, including further (though perhaps not exten-
sively prenylated) phenolic compounds as well.
Concerning the in vivo antioxidant activity of
isolated pure compounds, a number of studies have
been published on the stilbene mulberroside A,
diglycoside of oxyresveratrol, obtained from Morus
bombycis but also reported from Morus nigra roots
(see Fig. 6). Antioxidant properties of this compound
have been reported in connection with its antidiabetic
and liver protective activity. Oral treatment of STZ-
induced diabetic rats with 200–800 mg/kg of mulber-
roside A led to an improvement in several diabetic
markers including a slight decrease in blood glucose,
significant decrease in serum aspartate aminotrans-
ferase (AST), alanine aminotransferase (ALT), and
blood urea nitrogen, and increase in plasma insulin
levels. In addition to this, mulberroside A effectively
decreased lipid peroxidation, so that no significant
difference was found in this regard between the
diabetic control animals and those treated with the
smallest dose, 200 mg/kg (Heo et al. 2007). In
addition to a rather mild in vitro superoxide scaveng-
ing activity (IC50 = 430 lg/mL), the oral administra-
tion of 100–600 mg/kg of mulberroside A 30 min
before inducing hepatotoxicity with CCl4 to rats
exerted a similarly strong protective activity as
silymarin, and significantly decrease AST and ALT
levels. Hepatoprotective activity exerted through an
antioxidant action was also confirmed by the inhibi-
tion of in vitro lipid peroxidation on rat liver
homogenate in the presence of Fe2?/ascorbic acid,
and by the prevention of serious hystopathological
changes caused by the CCl4 treatment (Jin et al.
2006, 2007). In vivo antioxidant studies available on
Morus nigra extracts and mulberroside A are summa-
rized in Table 1.
Morusin is a potent and versatile antitumor
constituent of M. nigra roots
Antitumor properties of antioxidants have long been in
the focus of extensive research, and keep attracting a
popular attention with high expectations. Such com-
pounds can participate in various redox cycles and,
depending on the conditions, they can also contribute
to the oxidative stress, and induce oxidative cell death
of cancer cells. Accordingly, strong connection
appears to exist between the antioxidant activity and
anticancer potential of a compound (Klaunig et al.
2011; Kotecha et al. 2016). Nevertheless, there is
much related controversy: increased risk of cancer has
also been attributed to certain antioxidants in some
special cases (for a related review, see e.g. Saeidnia
and Abdollahi2013), demonstrating well the complex-
ity of the situation.
Morusin is a major phenolic antioxidant ofM. nigra
roots (De souza et al. 2000), whose antitumor prop-
erties have recently become into the focus of intensive
studies (Table 2). In connection with its antioxidant
activity, morusin was identified as a potent chemo-
preventive agent in vitro, protecting JB6 P? mouse
epidermal cells against the ROS-induced malignant
transformations upon phorbol ester treatment. Pre-
treatment with non-cytotoxic amounts (2.5–7.5 lM)
of morusin significantly mitigated the ROS production
induced by 12-O-tetradecanoylphorbol-13-acetate
(TPA), and consequently suppressed the TPA-induced
transactivation of activator protein 1 (AP-1) and
nuclear factor-jB (NF-jB).Moreover, TPA-promoted
cell growth and malignant up-regulation of cell
surface proteins (N-cadherin and vimentin) were also
reduced by morusin (Cheng et al. 2017).
Morusin was found to exert in vitro cytotoxicity
against cancer cell lines of various origin, including
e.g. pancreas, cervical and colorectal (Kim et al. 2016;
Wang et al. 2013; Lee et al. 2008). Morusin induced
apoptosis in HT-29 colorectal carcinoma cells through
caspase 8 subsequently leading to the activation of
caspase 9 and 3, and was suggested to cause a decrease
in the phosphorylation of PDK1, PI3 K and Akt,
leading to the downregulation of IKK-a, IKK-b and
IjB-a, hence suppressing NF-jB (Lee et al. 2008).
Morusin also demonstrated anti-invasive activity on
SK-Hep1 cells in non-cytotoxic concentrations, and
the suppression of the signal transducer and activator
of transcription 3 (STAT3; an oncogene with an
important role in cancer cell survival and prolifera-
tion) and NF-jB signaling was suggested as the two
key mechanisms behind. The in vitro results were also
confirmed in nude mice, whose lung metastasis upon
i.v. injection with SK-Hep1 cells was reduced when
pre-treated with morusin, and Western blots of the
lung tissues also gave consistent results with those
observed in vitro (Lin et al. 2015). STAT3 inhibition
by morusin was also reported in various pancreatic
carcinoma cell lines. Interestingly, morusin treatment
led to an accumulation of different phases in the cell
Phytochem Rev (2018) 17:1031–1045 1039
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cycle depending on the tested pancreatic cell line, and
induced both early and late apoptosis (Kim et al.
2016). Considerable selectivity in the in vitro cyto-
toxic activity of morusin was observed in a variety of
breast cancer cell lines as compared to immortalized
normal breast MCF10A cells. When studying apopto-
sis-related proteins regulated by STAT3, a suppres-
sion of the anti-apoptotic protein Survivin and over-
expression of the pro-apoptotic protein B cell lym-
phoma 2-associated-x protein (Bax) was observed.
The rate of apoptosis, however, was found lower than
expected from the corresponding cytotoxicity results,
suggesting that the effect of morusin also involves
necrosis and/or autophagy. (Kang et al. 2017). This
appears to be consistent with parallel results: morusin
was found to indeed induce autophagy through
activating AMPK and inhibiting mTOR, which
increased cell survival. Applying the autophagy
inhibitor 3-methyladenine, however, greatly increased
the rate of apoptotic cells (Cho et al. 2017).
Several in vivo studies confirmed the above obser-
vations on the antitumor potential of morusin. It had a
marked antitumor effect on H22 hepatocarcinoma-
transplanted mice and activity of morusin on the
expression of p53, Survivin, CyclinB1, and particu-
larly on that of caspase-3 and NF-jB was identified as
possible mechanism (Wan et al. 2014) coherently with
previous reports. Morusin was most recently reported
as an anti-angiogenetic agent: in vitro inhibition of the
proliferation, migration and tube formation of human
umbilical vein endothelial cells (HUVECs) was found,
confirmed by the in vivo inhibition of hepatocellular
HepG2 xenografts’ tumor growth and angiogenesis.
Both constitutive and interleukin-6 (IL-6) induced
Table 1 In vivo antioxidant activity of Morus nigra extracts and mulberroside A
Extract/compound Compounds
identified
Treatment Model Effect and mode of action Reference
Hot (boiling)
water extract of
M. nigra leaves
None 400 mg/kg,
per os,
0–20 days of
pregnancy
pregnant,
STZ-
induced
diabetic
rats
Diabetic dams: no glycemic changes, MDA
levels ;, cholesterol, triglycerides and
VLDL ;; non-diabetic rats: SOD :;
fetuses from diabetic rats: smaller
regardless of treatment, but skeletal and
visceral anomalies ;
Volpatoa et al.
(2011)
Ethanol extract of
M. nigra fruits
None; UV
absorbance
correlated with
that of rutin
100–400 mg/
kg, per os,
for 30 days
Kunming
strain
normal
mice
Serum and liver MDA ; and SOD activity
:, liver CAT :, blood and liver GSH-PX
:; spleen Langhans cells :
Feng et al.
(2015)
Methanol extract
of M. nigra
Leaves
Phenolic acids
(VA 632 lg/g,
CA 555 lg/g)
50 or 100 mg/
kg, per os,
for 60 days
D-galactose
treated
mice
Serum, brain and liver: MDA level
augmentation ;, SOD, GSH-PX, and
CAT activity :; improvement of
cognitive deficits; DNA damage
protection against UV and H2O2
Turgut et al.
(2016)
Mulberroside Aa n.a. 100–600 mg/
kg, per os,
30 min
before CCl4
CCl4-
induced
liver
damage in
rats
Hepatoprotective activity comparable to
that of silymarin; AST and ALT levels ;;
prevention of hystopathological changes;
Fe2?/ascorbic acid stimulated lipid
peroxidation ; in liver homogenates
Jin et al.
(2006, 2007)
Mulberroside Aa n.a. 200–800 mg/
kg
STZ-
induced
diabetic
rats
Lipid peroxidation ;, and improved islet
morphology in pancreas; diabetic
markers improved: blood glucose ;,
serum aspartate aminotransferase (AST)
;, alanine aminotransferase (ALT), and
blood urea nitrogen ;, plasma insulin
levels :, liver CYP-2E1 mRNA ;
Heo et al.
(2007)
VA vanillic acid, CA chlorogenic acid, n.a. not applicable
aIsolated from the roots of Morus bombycis, but reported to be present in M. nigra roots
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Table 2 In vitro and in vivo antitumor studies on morusin
Type of
study
Type of cancer Cancer cell line used Concentration of
morusin
Effect and mode of action Reference
In vitro Human colorectal
carcinoma
HT-29 29 lM Sub-G1 phase :, DNA
fragmentation, chromatin
condensation, PDK1, PI3 K,
IKK-a, IKK-b, and IkB-a
phosphorylation ; =[NF-kB ;;
caspase-8, -9 and -3 activation
Lee et al.
(2008)
In vitro Human cervical
cancer stem
cells
Non-adhesive culture of
HeLa
1–4 lM Proliferation, tumor sphere
formation and migration of
human cervical CSCs ;,
apoptosis, NF-jBp65 ;, Bcl-2 ;
Wang
et al.
(2013)
In vivo Hepatic
carcinoma
H22 cells 10–40 mg/kg p53, Survivin, CyclinB1,
Caspase-3 expression:, NF-jB
expression ;
Wan
et al.
(2014)
In vitro
and
in vivo
Human and
murine breast
cancer
MCF7, MDA-MB-231,
MCF-10A; murine 4 T1
and EMT6
4–8 lg/mL in vitro, 5
or 10 mg/kg i.p. in
MCF7 xenografts
Forcing differentiation of cancer
cells and xenograft tissue into
adipose like cells, accumulation
of lipid droplets, C/EBP b and
PPARc :, adipsin D, and
perilipin mediated adipogenic
differentiation and lipoapoptosis
Li et al.
(2015)
In vivo Human hepatic
adenocarcinoma
SK-Hep1 0–15 lM Cell matrix adhesion and cell
motility ;; modulation of EMT
through E-cadherin expression
:, vimentin and a2-, a6-, b1-
integrin expression ;; MMP-2
and -9 ; through STAT3 and
NF-jB ;
Lin et al.
(2015)
In vitro Human
Pancreatic
adenocarcinoma
AsPC-1, BxPC-3, MIA
PaCa-2 and PANC-1
20 lM Pro-apoptotic and anti-invasive:
STAT3 phosphorylation ;
through SHP-1 and SHP-2,
nuclear translocation of
p-STAT3 and STAT3 ;, STAT3
DNA binding ;, JAK1/JAK2,
and Src activation ;, caspase-3
activation
Kim et al.
(2016)
In vitro
and
in vivo
Human
glioblastoma
cancer stem
cells
WJ1, GSCs from non-
adhesive culturing; L02
1–5 lg/mL in vitro;
5–20 mg/kg in vivo
GSCs growth in vitro and in vivo
;, stemness of GSCs ;: CD133,
nestin, Oct4, and Sox2 ;;
induction of adipocyte-like
trans-differentiation and
apoptosis
Guo et al.
(2016)
In vitro Human breast
cancer
MCF7, MDA-MB-231,
MDA-MB-157, MDA-
MB-453; MCF 10A
0–20 lM Apoptosis through caspase-3 and -
9 :, B-cell lymphoma
2-associated-x protein (Bax) :,
Survivin ;; little effect on
normal human breast epithelial
cells (MCF10A)
Kang
et al.
(2017)
Phytochem Rev (2018) 17:1031–1045 1041
123
phosphorylation of STAT3 was inhibited, and VEGF,
MMP2, MMP9, and VEGFR2 were down-regulated
both in vitro and in vivo (Gao et al. 2017). Interest-
ingly, low-dose morusin treatment forced breast
cancer cells and xenograft tissue to differentiate into
adipose like cells accumulating lipid droplets and
over-expressing transcription factors C/EBP b and
PPARc, as well as adipogenic proteins adipsin D, and
perilipin (Li et al. 2015). Most recently, morusin was
found to inhibit gastric cancer cell proliferation and
tumor growth by down-regulating the oncogene
protein c-Myc both in vitro and in vivo, and that cells
engineered to over-express c-Myc can bypass the G1
phase cell cycle arrest induced by this compound
(Wang et al. 2017).
Morusin holds promise against cancer stem cells
Cancer stem cells (CSCs) are a cell sub-population
within the cancer tissue that seem to play a major role
in the frequent failure in chemotherapy: due to their
chemo-resistance, self-renewal and tumor initiating
capacity, the surviving CSCs can induce tumor
relapse. Accordingly, it is insufficient to achieve
tumor regression but a special attention is needed to
also eradicate the rare CSC population (Wicha et al.
2006). When testing morusin against cervical CSCs,
obtained through a non-adhesive culturing of HeLa
cells, it was found to dose-dependently suppress their
proliferation, tumor sphere formation and migration,
and it was inducing high rates of apoptosis at as low as
2–4 lM concentration (Wang et al. 2013). In a most
recent study by the same group, morusin was inves-
tigated for its potential against glioblastoma stem cells
(GSCs). Glioblastoma multiforme is one of the most
agressive types of cancer with a very poor prognosis,
and GSCs are believed to play a central role in this.
Morusin was able to target GSCs with a ca. 2-folds
selective in vitro cytotoxicity over that exerted on
parental glioblastoma cells and ca. 10-folds over that
on normal liver cells, and it could significantly inhibit
the growth of in vivo glioblastoma xenografts initiated
by GSCs (Guo et al. 2016). Coherently with the above-
mentioned results of (Li et al. 2015) on breast cancer
cells, GSCs could also be differentiated to adipocytes
by lower, non-cytotoxic, 0.5–2.0 lg/mL doses of
morusin, with a significant decrease of stemness
Table 2 continued
Type of
study
Type of cancer Cancer cell line used Concentration of
morusin
Effect and mode of action Reference
In vitro
and
In vivo
Human cervical
cancer
HEK293T, HeLa, HepG2,
HCT116, A549, MCF7,
Hep2
30 lM LC3-II accumulation, p-ULK1
(both at Ser317 and Ser 757) :
in HeLa cells, AMPK activity :,
mTOR activity
; =[ autophagy;
morusin ? autophagy
inhibitor =[ antitumor efficacy
:
Cho et al.
(2017)
In vitro
and
in vivo
Hepatocellular
carcinoma
Hep3B, HepG2, human
normal liver cells
(LO2), human umbilical
vein endothelial cells
(HUVECs)
4–8 lg/mL in HCC
cells, 1–3 lg/mL in
HUVECs, 5–15 mg/
kg in HepG2
xenografts
Apoptosis through caspase-3 and
Bax/Bcl-2 expression ratio :;
in vitro proliferation, migration,
and tube formation of HUVECs
;, angiogenic proteins in HCC
cells and HUVECs ;; in vivo
angiogenesis ;; attenuation of
the IL-6/STAT3 signaling
pathway
Gao et al.
(2017)
In vitro
and
in vivo
Human gastric
cancer
MKN45 and SGC7901 1–5 mg/L in vitro,
50 mg/kg i.p. in
xenografts
CDK2, CDK4, Cyclin D1 and
Cyclin E1 ;; c-Myc ; and
c-Myc protein binding to the
E-Box regions ;; over-
expressing c-Myc counteracts
antitumor activity
Wang
et al.
(2017)
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marker proteins CD133, nestin, Oct4, and Sox2, and
with a significant increase of PPARc, adipsin D,
adipocyte lipid binding protein (ap2), and perilipin
(Guo et al. 2016). On the other hand, slightly higher,
3–5 lg/mL doses of morusin already induced apop-
tosis in GSCs. These studies indicate that morusin
might have a serious potential in targeting cancer stem
cells, and its phenotypic effects resulting in transdif-
ferentiation may provide valuable for current efforts
towards the development of new therapeutic strategies
(Shekhani et al. 2013).
Summary
Various preparations of Morus nigra have been
playing an important role in traditional medicine since
ancient times, and pharmacological studies over the
past 80 years indicate a broad spectrum of biological
activities. The roots of this plant show an outstand-
ingly rich and diverse chemical composition particu-
larly concerning phenolic compounds, including
prenylated and geranylated constituents and Diels–
Alder type adducts with a wide variety of ring systems.
Many of these compounds showed potent in vitro
antioxidant activity against various experimental
models of free radical scavenging. While such assays
can hardly be considered therapeutically relevant,
many of the traditional uses ofM. nigrawould suggest
a potent in vivo antioxidant activity behind these.
Unfortunately, in vivo evidence supporting this is very
limited, and no particular in vivo studies are available
for traditionally utilized extracts of the root bark of the
plant.
Morusin, a major phenolic antioxidant of M. nigra
root bark, seems to have a bright future ahead.
Mounting in vitro and in vivo evidence suggests its
promising activity against various types of cancers,
and its selective activity against cancer stem cells,
including its capacity to differentiate them, makes it a
potentially valuable lead for related drug development
initiatives.
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